Skip to main content

Deer Management Co. LLC

13F filer · CIK 0001494127
Reported Aug 14, 2026
Net buyer this quarter
13F portfolio value$812MU.S. long equity reported on 13F
Positions91 new · 1 closed
Net flow last quarter+$171MBuys minus sells
Top 10 positions weight100.0%Concentration

Holdings

13F · last 4 quarters free
Scroll for earlier quarters
CompanyValue% of portfolio% of companyPOSITION CHANGE qoq %First reported
Q2 2026Reported Aug 14, 20269 positions
STUBStubHub Holdings, Inc.$284M34.92%Not reportedNot reportedQ3 2025
XNDUXanadu Quantum Technologies Ltd$276M33.97%7.65%NewQ2 2026
HNGEHinge Health, Inc.$158M19.51%11.65%-27.5%Q1 2026
LAWCS Disco, Inc.$32.7M4.03%13.34%Not reportedQ4 2021
TTANServiceTitan, Inc.$32M3.94%12.91%-9.9%Q4 2024
KYMRKymera Therapeutics, Inc.$14.4M1.78%0.15%Not reportedQ4 2021
SPIRSpire Global, Inc.$10M1.23%Not reported-24.5%Q4 2021
GUTSFractyl Health, Inc.$3.79M0.47%3.01%Not reportedQ1 2024
TCRXTScan Therapeutics, Inc.$1.22M0.15%5.19%Not reportedQ4 2021
Q1 2026Reported May 15, 20269 positions
TTANServiceTitan, Inc.$322M51.68%14.32%-12.6%Q4 2024
STUBStubHub Holdings, Inc.$138M22.10%Not reportedNot reportedQ3 2025
HNGEHinge Health, Inc.$102M16.32%16.08%NewQ1 2026
LAWCS Disco, Inc.$33.1M5.31%13.49%Not reportedQ4 2021
KYMRKymera Therapeutics, Inc.$10.5M1.69%0.15%-45.5%Q4 2021
SPIRSpire Global, Inc.$8.97M1.44%Not reportedNot reportedQ4 2021
FVRRFiverr International Ltd.$5.63M0.90%1.56%Not reportedQ4 2021
GUTSFractyl Health, Inc.$2.19M0.35%3.01%Not reportedQ1 2024
TCRXTScan Therapeutics, Inc.$1.26M0.20%5.19%Not reportedQ4 2021
Q4 2025Reported Feb 17, 20268 positions
TTANServiceTitan, Inc.$617M60.00%16.37%-7.8%Q4 2024
STUBStubHub Holdings, Inc.$298M28.98%Not reportedNot reportedQ3 2025
LAWCS Disco, Inc.$67.1M6.53%13.68%Not reportedQ4 2021
KYMRKymera Therapeutics, Inc.$18M1.75%0.28%-29.2%Q4 2021
FVRRFiverr International Ltd.$11.1M1.08%1.56%Not reportedQ4 2021
GUTSFractyl Health, Inc.$10.5M1.02%3.11%Not reportedQ1 2024
SPIRSpire Global, Inc.$5.35M0.52%Not reportedNot reportedQ4 2021
TCRXTScan Therapeutics, Inc.$1.25M0.12%5.19%Not reportedQ4 2021
Q3 2025Reported Nov 14, 20259 positions
TTANServiceTitan, Inc.$634M56.73%17.76%-22.7%Q4 2024
STUBStubHub Holdings, Inc.$371M33.21%Not reportedNewQ3 2025
LAWCS Disco, Inc.$55.9M5.00%13.85%Not reportedQ4 2021
KYMRKymera Therapeutics, Inc.$18.4M1.65%0.45%Not reportedQ4 2021
FVRRFiverr International Ltd.$13.7M1.23%1.52%Not reportedQ4 2021
SPIRSpire Global, Inc.$7.84M0.70%Not reportedNot reportedQ4 2021
GUTSFractyl Health, Inc.$7.59M0.68%3.61%Not reportedQ1 2024
NEUENeuehealth, Inc.$6.66M0.60%11.07%Not reportedQ1 2024
TCRXTScan Therapeutics, Inc.$2.27M0.20%5.19%Not reportedQ4 2021
Premium opens every quarter this fund has filed

Not investment advice. We make every effort to keep the information on SpoorBase accurate, but errors may occur. SpoorBase does not guarantee the accuracy or completeness of any data, and any use of the information is at the user’s sole responsibility. Valuation multiples are calculated by SpoorBase and may contain errors. See Disclosures. © 2026 SpoorBase. All rights reserved.